Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03280 | 34062716 | Int J Mol Sci | Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. | 2021 | Details |
| A03281 | 34062584 | Dtsch Med Wochenschr | [Alpha-1 antitrypsin deficiency: cause and cofactor for liver disease]. | 2021 | Details |
| A03284 | 34061469 | J Cachexia Sarcopenia Muscle | Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases. | 2021 | Details |
| A03307 | 34050922 | Eur J Clin Invest | Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. | 2021 | Details |
| A03308 | 34050561 | J Gastroenterol Hepatol | Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept. | 2021 | Details |
| A03314 | 34049335 | Invest Radiol | Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A03317 | 34047448 | Mol Nutr Food Res | Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline-Deficient (MCD) Diet-induced Nonalcoholic Steatohepatitis (NASH) Mice. | 2021 | Details |
| A03325 | 34043691 | PLoS One | Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study. | 2021 | Details |
| A03328 | 34043368 | J Proteome Res | Serum Bile Acid Profiles Improve Clinical Prediction of Nonalcoholic Fatty Liver in T2DM patients. | 2021 | Details |
| A03330 | 34041467 | JHEP Rep | A nationwide population-based prospective study of cirrhosis in Iceland. | 2021 | Details |
| A03337 | 34037296 | Liver Int | Impact of major depression and antidepressant use on alcoholic and non-alcoholic fatty liver disease: A population-based study. | 2021 | Details |
| A03343 | 34034671 | BMC Gastroenterol | Waist-to-height ratio and non-alcoholic fatty liver disease in adults. | 2021 | Details |
| A03348 | 34032730 | Medicine (Baltimore) | Acupuncture for type 2 diabetes mellitus with nonalcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2021 | Details |
| A03366 | 34027276 | Hepatol Commun | The Patient's Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age. | 2021 | Details |
| A03368 | 34027267 | Hepatol Commun | SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH. | 2021 | Details |
| A03369 | 34027266 | Hepatol Commun | The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. | 2021 | Details |
| A03372 | 34027109 | Clin Exp Hepatol | Non-alcoholic fatty liver disease and lipotoxicity. | 2021 | Details |
| A03381 | 34023517 | Spine J | Cardiovascular and metabolic morbidity following spinal cord injury. | 2021 | Details |
| A03386 | 34022107 | Liver Int | A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity. | 2021 | Details |
| A03388 | 34019941 | J Hepatol | The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease. | 2021 | Details |
| A03400 | 34015596 | Int Immunopharmacol | Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies. | 2021 | Details |
| A03405 | 34014044 | Pharmacol Res Perspect | Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision-cut liver slices. | 2021 | Details |
| A03406 | 34013366 | Int J Mol Med | Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review). | 2021 | Details |
| A03409 | 34012007 | Sci Rep | Profiling of tumour-associated microbiota in human hepatocellular carcinoma. | 2021 | Details |
| A03426 | 34004161 | Gastroenterology | Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03436 | 34001028 | BMC Gastroenterol | Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. | 2021 | Details |
| A03443 | 33998102 | Hepatol Res | Myostatin as a fibroblast-activating factor impacts on postoperative outcome in patients with hepatocellular carcinoma. | 2021 | Details |
| A03458 | 33993608 | Liver Int | Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease. | 2021 | Details |
| A03461 | 33992698 | J Hepatol | Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. | 2021 | Details |
| A03486 | 33987313 | Ann Transl Med | Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. | 2021 | Details |
| A03495 | 33983444 | Nephrol Dial Transplant | Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus. | 2022 | Details |
| A03497 | 33982805 | J Ultrasound Med | Reliability of Performing Multiparametric Ultrasound in Adult Livers. | 2021 | Details |
| A03502 | 33979963 | Zhonghua Gan Zang Bing Za Zhi | [Comparative study of clinicopathological features, and risk factors of advanced fibrosis between genders with non-alcoholic fatty liver disease]. | 2021 | Details |
| A03517 | 33973269 | Hepatology | A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD. | 2021 | Details |
| A03524 | 33970131 | J Vis Exp | Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH. | 2021 | Details |
| A03565 | 33952449 | Anticancer Res | Obesity and Liver Cancer in Japan: A Comprehensive Review. | 2021 | Details |
| A03572 | 33948987 | FASEB J | Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. | 2021 | Details |
| A03586 | 33941292 | J Health Popul Nutr | Study on the independent effect of thyroid hormone based on uric acid level on NAFLD. | 2021 | Details |
| A03598 | 33937292 | Front Med (Lausanne) | Test-Retest Reliability of the Assessment of Fatty Liver Disease Using Low-Dose Computed Tomography in Cardiac Patients. | 2021 | Details |
| A03604 | 33935282 | Int J Obes (Lond) | The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. | 2021 | Details |
| A03625 | 33925992 | J Clin Med | Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis. | 2021 | Details |
| A03626 | 33925827 | Int J Mol Sci | Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. | 2021 | Details |
| A03648 | 33920792 | J Clin Med | Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes. | 2021 | Details |
| A03655 | 33918456 | Int J Mol Sci | Relationship between NAFLD and Periodontal Disease from the View of Clinical and Basic Research, and Immunological Response. | 2021 | Details |
| A03665 | 33915261 | J Nutr Biochem | Consumption of soybean or olive oil at recommended concentrations increased the intestinal microbiota diversity and insulin sensitivity and prevented fatty liver compared to the effects of coconut oil. | 2021 | Details |
| A03681 | 33905771 | Clin Gastroenterol Hepatol | A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03688 | 33901779 | Ecotoxicol Environ Saf | Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants. | 2021 | Details |
| A03699 | 33898961 | JHEP Rep | Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. | 2021 | Details |
| A03705 | 33897464 | Front Physiol | Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease. | 2021 | Details |
| A03726 | 33889834 | Metabol Open | Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study. | 2021 | Details |
| A03753 | 33877366 | Diabetologia | Liver-targeting drugs and their effect on blood glucose and hepatic lipids. | 2021 | Details |
| A03762 | 33871465 | J Vis Exp | Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish. | 2021 | Details |
| A03780 | 33866274 | J Stroke Cerebrovasc Dis | Liver Fibrosis is Associated with Ischemic Stroke Risk in Women but not Men: The REGARDS Study. | 2021 | Details |
| A03840 | 33852508 | Eur J Gastroenterol Hepatol | The role of nursing care in the type 2 diabetes treatment associated with chronic liver diseases. | 2022 | Details |
| A03843 | 33851458 | Hepatology | Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge. | 2021 | Details |
| A03854 | 33845089 | J Lipid Res | The lipidome in nonalcoholic fatty liver disease: actionable targets. | 2021 | Details |
| A03855 | 33844928 | Child Obes | Omega-3 Use for the Treatment of Hypertriglyceridemia, Low High-Density Lipoprotein Cholesterol Levels, and Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2021 | Details |
| A03913 | 33821832 | Clin Transl Gastroenterol | Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study. | 2021 | Details |
| A03916 | 33818707 | Jpn J Radiol | The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03919 | 33817364 | Heliyon | Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease. | 2021 | Details |
| A03923 | 33815863 | World J Gastrointest Pathophysiol | Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. | 2021 | Details |
| A03924 | 33815743 | Ther Adv Endocrinol Metab | Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data. | 2021 | Details |
| A03939 | 33811619 | Eat Weight Disord | Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study. | 2021 | Details |
| A03948 | 33810315 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level. | 2021 | Details |
| A03968 | 33806527 | Pharmaceuticals (Basel) | The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. | 2021 | Details |
| A03970 | 33805912 | Int J Mol Sci | Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling. | 2021 | Details |
| A03977 | 33804296 | J Clin Med | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction? | 2021 | Details |
| A03986 | 33801023 | Nutrients | Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. | 2021 | Details |
| A03991 | 33799865 | Nutrients | A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones. | 2021 | Details |
| A04000 | 33794741 | Autophagy | The ménage à trois of autophagy, lipid droplets and liver disease. | 2021 | Details |
| A04002 | 33794385 | Eur J Med Chem | Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration. | 2021 | Details |
| A04008 | 33790913 | Front Immunol | Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity. | 2021 | Details |
| A04044 | 33777700 | Toxicol Rep | Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis. | 2021 | Details |
| A04058 | 33773656 | Food Res Int | Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. | 2021 | Details |
| A04060 | 33773192 | Phytomedicine | Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. | 2021 | Details |
| A04082 | 33766233 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | [Down-regulation of IL-25 accompanied by a decrease in the number of M2 macrophages in patients of non-alcoholic fatty liver disease with significant liver fibrosis]. | 2021 | Details |
| A04093 | 33762736 | Nature | Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH. | 2021 | Details |
| A04102 | 33759300 | Diabetes Metab Res Rev | Advanced liver fibrosis and the metabolic syndrome in a primary care setting. | 2021 | Details |
| A04117 | 33751456 | Curr Obes Rep | Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives. | 2021 | Details |
| A04124 | 33748727 | JHEP Rep | Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation. | 2021 | Details |
| A04133 | 33746083 | J Hepatol | Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. | 2021 | Details |
| A04135 | 33745998 | J Pediatr | Under-reporting of Hepatic Steatosis in Children: A Missed Opportunity for Early Detection. | 2021 | Details |
| A04145 | 33742744 | J Diabetes Investig | Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status. | 2021 | Details |
| A04153 | 33739636 | Korean J Radiol | Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard. | 2021 | Details |
| A04161 | 33733078 | JHEP Rep | European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease? | 2021 | Details |
| A04168 | 33730774 | Ultrasonography | Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression. | 2021 | Details |
| A04186 | 33723340 | Sci Rep | Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease. | 2021 | Details |
| A04215 | 33710478 | Glycoconj J | MALDI-TOF mass spectrometry imaging for N-glycans on FFPE tissue sections of mouse NASH liver through Sialic acid Benzylamidation. | 2021 | Details |
| A04223 | 33708783 | Front Med (Lausanne) | Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A04227 | 33707081 | Best Pract Res Clin Endocrinol Metab | Gut microbiome and bile acids in obesity-related diseases. | 2021 | Details |
| A04233 | 33704100 | Clin Transl Gastroenterol | Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study. | 2021 | Details |
| A04258 | 33685968 | Gut | Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. | 2021 | Details |
| A04268 | 33683797 | Int J Clin Pract | The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study. | 2021 | Details |
| A04297 | 33672887 | Toxins (Basel) | Fungi-Bacteria Correlation in Alcoholic Hepatitis Patients. | 2021 | Details |
| A04298 | 33672864 | Life (Basel) | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. | 2021 | Details |
| A04313 | 33669288 | Int J Environ Res Public Health | Relationships between Socioeconomic Status, Handgrip Strength, and Non-Alcoholic Fatty Liver Disease in Middle-Aged Adults. | 2021 | Details |
| A04321 | 33665755 | Obes Surg | Decision Tree for the Performance of Intraoperative Liver Biopsy During Bariatric Surgery. | 2021 | Details |
| A04345 | 33656663 | Hepatol Int | Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease. | 2021 | Details |
| A04353 | 33651661 | Gut Microbes | Links between gut microbiome composition and fatty liver disease in a large population sample. | 2022 | Details |
| A04363 | 33647632 | Clin Imaging | Digital image analysis of ultrasound images using machine learning to diagnose pediatric nonalcoholic fatty liver disease. | 2021 | Details |